What should I know about the recent meningococcal disease outbreak in Virginia?

An outbreak of meningococcal disease occurred in Virginia between 2022 and 2024. This event involved a specific strain of bacteria called Neisseria meningitidis serogroup Y, sequence type 1466. The investigation found 36 genetically related cases, which included seven deaths, resulting in a case fatality rate of 19.4% ¹⁰.

What the research says

A major finding of the investigation was that the majority of patients, 63.9%, were in the age group of 30 to 60 years. This is unusual because meningococcal disease often affects adolescents and young adults ¹⁰⁹. Additionally, 78.0% of the patients were non-Hispanic Black or African American ¹⁰.

The outbreak investigation did not identify any common exposures, affiliations, or risk factors among the cases. Because no defined population at risk could be identified, a broad vaccination campaign for the general public was not recommended ¹⁰. Instead, the Virginia Department of Health recommended vaccination for a subset of close contacts of patients based on specific IMD risk factors and age ranges similar to those of the patients with identified cases ¹⁰.

Meningococcal disease is a severe, rapidly progressive infection that can lead to meningitis or meningococcemia. It carries a high rate of morbidity and mortality. Early symptoms may mimic a benign viral illness, which can delay treatment with serious consequences. Prompt treatment with antibiotics is essential, ideally within one hour of clinical suspicion ⁸.

What to ask your doctor

• Was I exposed to someone with meningococcal disease in Virginia during the 2022-2024 outbreak period?
• Do I need antibiotic prophylaxis based on my specific exposure history?
• Should I receive a meningococcal vaccine, especially given my age and health status?
• Are there specific symptoms I should watch for that require immediate medical attention?